tiprankstipranks
Advertisement

ROPE - ETF AI Analysis

Compare

Top Page

ROPE

Coastal Compass 100 ETF (ROPE)

Rating:69Neutral
Price Target:
ROPE (Coastal Compass 100 ETF) earns a solid overall rating thanks to several strong core holdings like ConocoPhillips, Bristol-Myers Squibb, US Bancorp, Exxon Mobil, and Comcast, which bring healthy financial performance, reasonable valuations, and supportive earnings trends to the portfolio. The fund is held back somewhat by names such as CVS Health and Philip Morris, where bearish technical signals, leverage concerns, and specific business challenges add pressure. The main risk factor is that several key holdings show cautionary technical indicators and debt or revenue-growth issues, which could increase volatility even though the overall mix remains broadly diversified.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past month, three months, and year to date, indicating positive recent momentum.
Leading Holdings With Strong Gains
Several of the largest positions, including major retailers and energy companies, have delivered strong year-to-date performance that supports the fund’s returns.
Broad Sector Diversification
Holdings spread across financials, health care, industrials, consumer defensive, energy, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns for investors.
Heavy U.S. Concentration
With almost all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.
Mixed Performance Among Top Holdings
A few of the largest positions have shown weak or negative year-to-date performance, which can drag on the fund if those stocks continue to lag.

ROPE vs. SPDR S&P 500 ETF (SPY)

ROPE Summary

The Coastal Compass 100 ETF (ROPE) is a U.S.-focused fund that invests in about 100 large, well-known companies across many sectors, rather than tracking a specific index. Its holdings include familiar names like Target and Exxon Mobil, along with banks, health care firms, industrials, and more. Someone might consider this ETF to get instant diversification in big, established companies that can offer a mix of stability and growth potential. However, like any stock-based investment, its value can go up and down with the overall market, and it is still heavily tied to the performance of large U.S. companies.
How much will it cost me?The Coastal Compass 100 ETF has an expense ratio of 0.8%, meaning you’ll pay $8 per year for every $1,000 invested. This is higher than average because the fund is actively managed, which typically involves more research and trading compared to passively managed funds that track an index.
What would affect this ETF?The Coastal Compass 100 ETF, with its focus on large-cap U.S. companies across diverse sectors like health care, financials, and energy, could benefit from economic stability and sector-specific growth trends, such as advancements in health care or strong energy demand. However, it may face challenges from rising interest rates, which could pressure financial stocks, or regulatory changes impacting top holdings like Chevron and Pfizer. Broader market volatility could also affect its performance given its reliance on large-cap equities.

ROPE Top 10 Holdings

ROPE leans heavily into steady, large U.S. names, with a clear tilt toward financials, health care, and consumer defensives. Target and CVS have been doing much of the heavy lifting lately, with both stocks rising as investors reward their stable cash flows and defensive appeal. Simon Property and UPS are also pulling their weight, adding a bit of cyclical punch. On the flip side, Comcast has been dragging the fund, while Philip Morris and the big energy duo, Exxon and ConocoPhillips, have shown more mixed, stop‑and‑go performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
CVS Health5.90%$550.83K$133.62B55.86%
64
Neutral
Target5.76%$537.64K$59.14B23.62%
70
Neutral
Simon Property5.65%$526.72K$73.31B37.66%
70
Outperform
Philip Morris5.34%$498.33K$284.08B5.67%
61
Neutral
Exxon Mobil5.12%$477.48K$568.16B24.08%
74
Outperform
US Bancorp4.97%$463.84K$96.16B31.83%
76
Outperform
Bristol-Myers Squibb4.91%$458.47K$118.71B23.24%
78
Outperform
Conocophillips4.91%$458.09K$127.59B13.20%
78
Outperform
United Parcel4.87%$454.48K$94.06B7.46%
72
Outperform
Comcast3.98%$371.46K$84.98B-34.97%
74
Outperform

ROPE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
29.28
Positive
100DMA
28.86
Positive
200DMA
27.75
Positive
Market Momentum
MACD
0.24
Negative
RSI
59.87
Neutral
STOCH
72.15
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ROPE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 29.75, equal to the 50-day MA of 29.28, and equal to the 200-day MA of 27.75, indicating a bullish trend. The MACD of 0.24 indicates Negative momentum. The RSI at 59.87 is Neutral, neither overbought nor oversold. The STOCH value of 72.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ROPE.

ROPE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$9.32M0.81%
69
Neutral
$97.16M0.45%
69
Neutral
$96.55M0.80%
67
Neutral
$93.97M0.35%
73
Outperform
$92.27M0.93%
63
Neutral
$88.28M0.49%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ROPE
Coastal Compass 100 ETF
30.05
4.68
18.45%
ACEP
ARS Core Equity Portfolio ETF
FCUS
Pinnacle Focused Opportunities ETF
JOYT
JPMorgan Equity and Options Total Return ETF
EGGQ
NestYield Visionary ETF
JHDG
John Hancock Hedged Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement